Literature DB >> 20610619

How did the PSA system arise?

Stewart Justman1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20610619      PMCID: PMC2913063          DOI: 10.1258/jrsm.2010.100130

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  11 in total

Review 1.  Use of decision aids to support informed choices about screening.

Authors:  Alexandra Barratt; Lyndal Trevena; Heather M Davey; Kirsten McCaffery
Journal:  BMJ       Date:  2004-08-28

2.  Community programs. Breast cancer detection awareness.

Authors:  D J Fink
Journal:  Cancer       Date:  1989-12-15       Impact factor: 6.860

Review 3.  Prostate cancer: 4. Screening.

Authors:  F Meyer; Y Fradet
Journal:  CMAJ       Date:  1998-10-20       Impact factor: 8.262

4.  Putting the "informed" in informed consent about mammography.

Authors:  B K Rimer
Journal:  J Natl Cancer Inst       Date:  1995-05-17       Impact factor: 13.506

Review 5.  Screening for prostate cancer with prostate-specific antigen. An examination of the evidence.

Authors:  S H Woolf
Journal:  N Engl J Med       Date:  1995-11-23       Impact factor: 91.245

6.  Screening and prostate-cancer mortality in a randomized European study.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Antonio Berenguer; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Bert G Blijenberg; Sue M Moss; Harry J de Koning; Anssi Auvinen
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

7.  Mortality results from a randomized prostate-cancer screening trial.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Edward P Gelmann; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Richard B Hayes; Barnett S Kramer; Grant Izmirlian; Anthony B Miller; Paul F Pinsky; Philip C Prorok; John K Gohagan; Christine D Berg
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

8.  Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).

Authors:  Richard M Hoffman; Mick P Couper; Brian J Zikmund-Fisher; Carrie A Levin; Mary McNaughton-Collins; Deborah L Helitzer; John VanHoewyk; Michael J Barry
Journal:  Arch Intern Med       Date:  2009-09-28

Review 9.  Why is prostate cancer screening so common when the evidence is so uncertain? A system without negative feedback.

Authors:  David F Ransohoff; Mary McNaughton Collins; Floyd J Fowler
Journal:  Am J Med       Date:  2002-12-01       Impact factor: 4.965

10.  Public knowledge of benefits of breast and prostate cancer screening in Europe.

Authors:  Gerd Gigerenzer; Jutta Mata; Ronald Frank
Journal:  J Natl Cancer Inst       Date:  2009-08-11       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.